Vapotherm’s (NYSE:VAPO) lock-up period is set to end on Monday, May 13th. Vapotherm had issued 4,000,000 shares in its public offering on November 14th. The total size of the offering was $56,000,000 based on an initial share price of $14.00. After the end of the company’s lock-up period, major shareholders and company insiders will be able to sell their shares of the company.
Several brokerages recently commented on VAPO. Zacks Investment Research raised Vapotherm from a “sell” rating to a “hold” rating in a research report on Friday, April 26th. Canaccord Genuity increased their price target on Vapotherm from $22.00 to $27.00 and gave the company a “buy” rating in a research report on Wednesday, March 13th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. Vapotherm presently has a consensus rating of “Buy” and an average target price of $26.50.
Shares of NYSE VAPO opened at $17.85 on Monday. Vapotherm has a 52 week low of $14.70 and a 52 week high of $22.29. The company has a quick ratio of 4.84, a current ratio of 5.82 and a debt-to-equity ratio of 0.61. The company has a market cap of $308.98 million and a P/E ratio of -1.29.
Vapotherm (NYSE:VAPO) last issued its quarterly earnings results on Tuesday, March 12th. The company reported ($1.28) EPS for the quarter, beating the consensus estimate of ($1.40) by $0.12. The company had revenue of $11.69 million for the quarter, compared to analyst estimates of $11.00 million. As a group, equities research analysts anticipate that Vapotherm will post -2.86 EPS for the current year.
A number of hedge funds and other institutional investors have recently modified their holdings of VAPO. Arnhold LLC acquired a new position in Vapotherm during the fourth quarter valued at approximately $227,000. New York State Common Retirement Fund bought a new stake in Vapotherm in the fourth quarter valued at approximately $118,000. Dean Capital Investments Management LLC bought a new stake in Vapotherm in the fourth quarter valued at approximately $748,000. BlackRock Inc. bought a new stake in Vapotherm in the fourth quarter valued at approximately $6,248,000. Finally, Bank of New York Mellon Corp bought a new stake in Vapotherm in the fourth quarter valued at approximately $346,000. 47.50% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: This article was reported by American Banking News and is the property of of American Banking News. If you are reading this article on another domain, it was copied illegally and republished in violation of United States and international trademark and copyright law. The correct version of this article can be read at https://www.americanbankingnews.com/2019/05/06/vapotherm-incs-lock-up-period-to-end-on-may-13th-nysevapo.html.
Vapotherm, Inc, a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface.
Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.